Page last updated: 2024-12-11

eleutherobin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

eleutherobin: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6918335
CHEMBL ID504387
SCHEMBL ID12015046
MeSH IDM0284269

Synonyms (15)

Synonym
lew3mbq5wm ,
unii-lew3mbq5wm
174545-76-7
eleutherobin
CHEMBL504387
XOPYFXBZMVTEJF-PDACKIITSA-N
SCHEMBL12015046
DTXSID20893496
Q15410946
[(1s,2s,4r,8r,9s,10z,12r)-11-[[(2r,3s,4r,5r)-3-acetyloxy-4,5-dihydroxyoxan-2-yl]oxymethyl]-12-methoxy-1,5-dimethyl-8-propan-2-yl-15-oxatricyclo[10.2.1.04,9]pentadeca-5,10,13-trien-2-yl] (e)-3-(1-methylimidazol-4-yl)prop-2-enoate
HY-149027
CS-0566028
beta-d-arabinopyranoside, [3,4,4a,7,10,11,12,12a-octahydro-7-methoxy-1,10-dimethyl-4-(1-methylethyl)-11-[[3-(1-methyl-1h-imidazol-4-yl)-1-oxo-2-propenyl]oxy]-7,10-epoxybenzocyclodecen-6-yl]methyl, 2-acetate, [4r-[4r*,4as*,5z,7r*,10s*,11s*(e),12ar*]]-
eleutherobin [mi]
beta-d-arabinopyranoside, [(4r,4as,5z,7r,10s,11s,12ar)-3,4,4a,7,10,11,12,12a-octahydro-7-methoxy-1,10-dimethyl-4-(1-methylethyl)-11-[[(2e)-3-(1-methyl-1h-imidazol-4-yl)-1-oxo-2-propen-1-yl]oxy]-7,10-epoxybenzocyclodecen-6-yl]methyl, 2-acetate

Research Excerpts

Overview

Eleutherobin is a novel natural product isolated from a marine soft coral that is extremely potent for inducing tubulin polymerization in vitro. It is cytotoxic for cancer cells with an IC50 similar to that of paclitaxel.

ExcerptReferenceRelevance
"Eleutherobin is a novel natural product isolated from a marine soft coral that is extremely potent for inducing tubulin polymerization in vitro and is cytotoxic for cancer cells with an IC50 similar to that of paclitaxel. "( Eleutherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitaxel (Taxol).
Carboni, JM; Casazza, AM; Cornell, LA; Fairchild, CR; Fenical, W; Jensen, PR; Lindel, T; Long, BH; Wasserman, AJ, 1998
)
3.19
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID355718Cytotoxicity against human HeLa cells2003Journal of natural products, Apr, Volume: 66, Issue:4
(Z)-sarcodictyin A, a new highly cytotoxic diterpenoid from the soft coral Bellonella albiflora.
AID1404367Cytotoxicity against human CD133/CD44 positive PPT2 cells assessed as cell death at 0.01 to 10 uM after 72 hrs by MTT assay2018Journal of natural products, 03-23, Volume: 81, Issue:3
Quest for Efficacious Next-Generation Taxoid Anticancer Agents and Their Tumor-Targeted Delivery.
AID628149Antimitotic activity in human MCF7 cells assessed as mitotic arrest after 16 to 20 hrs by ELISA method2011Bioorganic & medicinal chemistry, Nov-15, Volume: 19, Issue:22
Marine diterpene glycosides.
AID1404361Cytotoxicity against human CD133/CD44 positive PC3MM2 cells assessed as cell death at 0.01 to 10 uM after 72 hrs by MTT assay2018Journal of natural products, 03-23, Volume: 81, Issue:3
Quest for Efficacious Next-Generation Taxoid Anticancer Agents and Their Tumor-Targeted Delivery.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (19.23)18.2507
2000's17 (65.38)29.6817
2010's4 (15.38)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.57

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.57 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index30.30 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.57)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews6 (23.08%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (76.92%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]